Literature DB >> 9034826

Early activation of microglia in the pathogenesis of fatal murine cerebral malaria.

I M Medana1, N H Hunt, T Chan-Ling.   

Abstract

Microglia are pluripotent members of the macrophage/monocyte lineage that can respond in several ways to pathological changes in the central nervous system. To determine their role in the pathogenesis of fatal murine cerebral malaria (FMCM) we have conducted a detailed study of the changes in morphology and distribution of retinal microglia during the progression of the disease. Adult CBA/T6 mice were inoculated with Plasmodium berghei ANKA. These mice died 7 days post inoculation (p.i.) with the parasite while exhibiting cerebral symptoms, increased permeability of the blood-brain barrier, and monocyte adherence to the vascular endothelium. Mice were injected i.v. with Monastral blue 2 h prior to sacrifice to identify "activated" monocytes, and their isolated retinae were incubated with the Griffonia simplicifolia (GS) lectin or reacted for the nucleoside diphosphatase enzyme to visualize microglia and the vasculature. Changes in microglial morphology were seen within 2-3 days p.i., that is, at least 3 days prior to the onset of cerebral symptoms and 4 days before death. Morphological changes included retraction of ramified processes, soma enlargement, an increasingly amoeboid appearance, and vacuolation. There was also increased staining intensity and redistribution of "activated" microglia toward retinal vessels, but no increase in density of NDPase-positive cells. The GS lectin only labeled a small population of microglia in the uninfected adult mouse retina. However, there was a striking increase in the focal density of GS-positive microglia during the progression of the disease. Extravasation of monocytes also was observed prior to the onset of cerebral symptoms. These results provide the first evidence that microglial activation is a critical component of the pathological process during FMCM.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9034826     DOI: 10.1002/(sici)1098-1136(199702)19:2<91::aid-glia1>3.0.co;2-c

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  38 in total

1.  Reactive changes of retinal microglia during fatal murine cerebral malaria: effects of dexamethasone and experimental permeabilization of the blood-brain barrier.

Authors:  I M Medana; T Chan-Ling; N H Hunt
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

Review 2.  Role of microglia in central nervous system infections.

Authors:  R Bryan Rock; Genya Gekker; Shuxian Hu; Wen S Sheng; Maxim Cheeran; James R Lokensgard; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

3.  Hematopoietic stem cells provide repair functions after laser-induced Bruch's membrane rupture model of choroidal neovascularization.

Authors:  Tailoi Chan-Ling; Louise Baxter; Aqeela Afzal; Nilanjana Sengupta; Sergio Caballero; Emilia Rosinova; Maria B Grant
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

4.  Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria.

Authors:  L A Sanni; S R Thomas; B N Tattam; D E Moore; G Chaudhri; R Stocker; N H Hunt
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

5.  Cannabinoid Receptor 2 Modulates Susceptibility to Experimental Cerebral Malaria through a CCL17-dependent Mechanism.

Authors:  Judith Alferink; Sabine Specht; Hannah Arends; Beatrix Schumak; Kim Schmidt; Christina Ruland; Ramona Lundt; Andrea Kemter; Andrea Dlugos; Janina M Kuepper; Karola Poppensieker; Matthias Findeiss; Önder Albayram; David-M Otte; Janine Marazzi; Jürg Gertsch; Irmgard Förster; Wolfgang Maier; Stefanie Scheu; Achim Hoerauf; Andreas Zimmer
Journal:  J Biol Chem       Date:  2016-07-29       Impact factor: 5.157

Review 6.  Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria.

Authors:  Chandy C John; Elizabeth Kutamba; Keith Mugarura; Robert O Opoka
Journal:  Expert Rev Anti Infect Ther       Date:  2010-09       Impact factor: 5.091

7.  Structure-activity relationship and mechanism of action studies of manzamine analogues for the control of neuroinflammation and cerebral infections.

Authors:  Jiangnan Peng; Sucheta Kudrimoti; Sivaprakasam Prasanna; Srinivas Odde; Robert J Doerksen; Hari K Pennaka; Yeun-Mun Choo; Karumanchi V Rao; Babu L Tekwani; Vamsi Madgula; Shabana I Khan; Bin Wang; Alejandro M S Mayer; Melissa R Jacob; Lan Chun Tu; Jürg Gertsch; Mark T Hamann
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

8.  Evidence for multiple pathologic and protective mechanisms of murine cerebral malaria.

Authors:  V M Jennings; A A Lal; R L Hunter
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

9.  The specific, reversible JNK inhibitor SP600125 improves survivability and attenuates neuronal cell death in experimental cerebral malaria (ECM).

Authors:  Sripada Santosh Anand; Mulaka Maruthi; Phanithi Prakash Babu
Journal:  Parasitol Res       Date:  2013-02-28       Impact factor: 2.289

10.  Predominance of interferon-related responses in the brain during murine malaria, as identified by microarray analysis.

Authors:  Jenny Miu; Nicholas H Hunt; Helen J Ball
Journal:  Infect Immun       Date:  2008-02-25       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.